Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae
Authors
Keywords
-
Journal
MICROBIOLOGY AND IMMUNOLOGY
Volume 61, Issue 6, Pages 195-205
Publisher
Wiley
Online
2017-05-02
DOI
10.1111/1348-0421.12487
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Theory and strategy for Pneumococcal vaccines in the elderly
- (2015) Ho Namkoong et al. Human Vaccines & Immunotherapeutics
- Keyhole limpet haemocyanin - a model antigen for human immunotoxicological studies
- (2014) Ashwin Swaminathan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial
- (2013) Ron Dagan et al. CLINICAL INFECTIOUS DISEASES
- PspA Family Distribution, unlike Capsular Serotype, Remains Unaltered following Introduction of the Heptavalent Pneumococcal Conjugate Vaccine
- (2012) Christina M. Croney et al. Clinical and Vaccine Immunology
- Issues and challenges in the development of pneumococcal protein vaccines
- (2012) Amy Sarah Ginsburg et al. Expert Review of Vaccines
- Development of a Lipopolysaccharide-Targeted Peptide Mimic Vaccine against Q Fever
- (2012) Y. Peng et al. JOURNAL OF IMMUNOLOGY
- The Nasal Dendritic Cell-Targeting Flt3 Ligand as a Safe Adjuvant Elicits Effective Protection against Fatal Pneumococcal Pneumonia
- (2011) Kosuke Kataoka et al. INFECTION AND IMMUNITY
- A Combination of Flt3 Ligand cDNA and CpG Oligodeoxynucleotide as Nasal Adjuvant Elicits Protective Secretory-IgA Immunity to Streptococcus pneumoniae in Aged Mice
- (2011) Y. Fukuyama et al. JOURNAL OF IMMUNOLOGY
- Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination
- (2011) Tselmeg Baatarjav et al. VACCINE
- Secretory-IgA Antibodies Play an Important Role in the Immunity to Streptococcus pneumoniae
- (2010) Y. Fukuyama et al. JOURNAL OF IMMUNOLOGY
- Natural Antibodies against Phosphorylcholine in Cardiovascular Disease
- (2009) Ulf De Faire et al. Annals of the New York Academy of Sciences
- Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection
- (2009) J. Cao et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Th17 cytokines and mucosal immunity
- (2009) Patricia J. Dubin et al. IMMUNOLOGICAL REVIEWS
- Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
- (2009) Tamara Pilishvili et al. JOURNAL OF INFECTIOUS DISEASES
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
- (2009) Katherine L O'Brien et al. LANCET
- Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
- (2008) Lisa A. Jackson et al. CLINICAL INFECTIOUS DISEASES
- Regulatory T cells and the induction of IL-17
- (2008) A Kitani et al. Mucosal Immunology
- Differentiation and homing of IgA-secreting cells
- (2008) J R Mora et al. Mucosal Immunology
- IL-23 and Th17 cytokines in intestinal homeostasis
- (2008) K J Maloy et al. Mucosal Immunology
- The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease
- (2008) Aras Kadioglu et al. NATURE REVIEWS MICROBIOLOGY
- Natural antibodies against phosphorylcholine as potential protective factors in SLE
- (2008) J. Su et al. RHEUMATOLOGY
- Immunological commonalities and distinctions between airway and digestive immunity
- (2008) Jun Kunisawa et al. TRENDS IN IMMUNOLOGY
- A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity
- (2008) Tatsuya Fukuiwa et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started